Survival and Follow-up Visit Condition of Patients with Small Cell Lung Cancer Treated by Integrated Traditional Chinese and Western Medicine based on the Internet Plus Traditional Chinese Medicine Chronic Disease Management Model

Jie HE; Conghuang LI; Mingxi SUN; Rui LIU; Baojin HUA

doi:10.13288/j.11-2166/r.2022.02.008

您当前的位置：

首页 >

文章列表页 >

Survival and Follow-up Visit Condition of Patients with Small Cell Lung Cancer Treated by Integrated Traditional Chinese and Western Medicine based on the Internet Plus Traditional Chinese Medicine Chronic Disease Management Model

更新时间：2022-01-14

- Survival and Follow-up Visit Condition of Patients with Small Cell Lung Cancer Treated by Integrated Traditional Chinese and Western Medicine based on the Internet Plus Traditional Chinese Medicine Chronic Disease Management Model
- Journal of Traditional Chinese Medicine Vol. 63, Issue 2, Pages: 137-142(2022)
- 作者机构：
  
  1.中国中医科学院广安门医院，北京市西城区北线阁5号，100053
  2.北京市丰台区南苑医院
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2022.02.008
  CLC：
- Received：25 March 2021，
  
  Revised：2021-09-25，
  
  Published：17 January 2022
- 稿件说明：
移动端阅览
何杰,李丛煌,孙铭禧等.“互联网+”中医慢病管理模式的中西医结合疗法治疗小细胞肺癌患者生存和复诊情况分析[J].中医杂志,2022,63(02):137-142.

HE Jie,LI Conghuang,SUN Mingxi,et al.Survival and Follow-up Visit Condition of Patients with Small Cell Lung Cancer Treated by Integrated Traditional Chinese and Western Medicine based on the Internet Plus Traditional Chinese Medicine Chronic Disease Management Model[J].Journal of Traditional Chinese Medicine,2022,63(02):137-142.
何杰,李丛煌,孙铭禧等.“互联网+”中医慢病管理模式的中西医结合疗法治疗小细胞肺癌患者生存和复诊情况分析[J].中医杂志,2022,63(02):137-142. DOI： 10.13288/j.11-2166/r.2022.02.008.

HE Jie,LI Conghuang,SUN Mingxi,et al.Survival and Follow-up Visit Condition of Patients with Small Cell Lung Cancer Treated by Integrated Traditional Chinese and Western Medicine based on the Internet Plus Traditional Chinese Medicine Chronic Disease Management Model[J].Journal of Traditional Chinese Medicine,2022,63(02):137-142. DOI： 10.13288/j.11-2166/r.2022.02.008.

摘要

目的

观察“互联网+”中医慢病管理模式的中西医结合疗法治疗小细胞肺癌患者的生存和复诊情况。

方法

采用队列研究的方法，60例小细胞肺癌患者按照患者意愿分为中医慢病管理组和对照组各30例。对照组患者给予西医规范化治疗和中药口服治疗，中医慢病管理组在对照组基础上再给予“互联网+”中医慢病管理，包括档案建立、健康宣教、中医特色疗法指导、定期随访和联盟家属及病友等。两组治疗时间不应少于3个月。两组患者4个化疗周期之后进入随访阶段，每3个月随访1次，末次随访时间为2019年12月31日。分别统计两组患者中位生存时间（MST）、中位无进展生存时间（mPFS）以及复诊情况（包括复诊调方依从性、复查依从性、复诊时间、病例资料获取度），并评价中医慢病管理组患者对中医慢病管理平台使用的满意度。

结果

中医慢病管理组与对照组MST分别为（20.97±3.43）个月和（18.03±1.91）个月，mPFS分别为（10.17±0.84）个月和（7.90±0.33）个月，两组MST和mPFS比较差异均无统计学意义（

＞0.05）。中医慢病管理组较对照组复诊调方依从性和复查依从性高，复诊调方时间短，病例资料获取度更及时且完整（

＜0.05）。中医慢病管理组患者对平台使用可行性调查中满意者14例（51.9%），满意度调查中满意者7例（25.9%）。

结论

中西医结合疗法可使小细胞肺癌患者获益，且在“互联网+”中医慢病管理模式下患者复诊情况更佳。

Abstract

Objective

To analyze survival and follow-up visit condition of patients with small cell lung cancer （SCLC） treated by integrated traditional Chinese and western medicine based on Internet Plus traditional Chinese medicine （TCM） chronic disease management model.

Methods

A cohort study was conducted， where patients with SCLC were included and classified into TCM chronic disease management group （30 cases） and control group （30 cases） according to patients' willingness. The control group was given routine western medicine and oral Chinese herbal medicine， while the TCM chronic disease management group additionally received Internet Plus TCM chronic disease management including file establishment， health education， typical TCM therapy guidance， regular follow-up and family members-patients alliance. Both group of patients all received three months of treatments. After four chemotherapy cycles， the patients were followed up every 3 months， and the last follow-up time was December 31st， 2019. The median survival time （MST）， the median progression-free survival（mPFS）， and follow-up outcomes （formula adjustment compliance， re-examination compliance， re-exmaination time， data acquisition） were assessed， and the degree of sa-tisfaction for using the chronic disease management platform in patients was evaluated.

Results

The MST of the TCM chronic disease management group was （20.97±3.43） months and that of the control group was （18.03±1.91） months； and mPFS of the two groups was （10.17±0.84） months and （7.90±0.33） months， respectively； there were no significant differences between two groups in MST and mPFS （

＞0.05）. Compared to the control group， the TCM chronic disease management group had higher compliance to the formula adjustment， higher rate of re-examination on time， shorter time for formula adjustment， and more timely and completely acquisition of data （

＜0.05）. The positive responses of the feasibility and the satisfaction of the Internet Plus platform usage were 14 （51.9%） and 7 （25.9%）， respectively.

Conclusion

Integrated traditioanl Chinese and Western medicine benefits the SCLC patients， and the prognosis is better when the Internet Plus TCM chronic disease management model is applied.

关键词

Keywords

references

MATHUR P ， SATHISHKUMAR K ， CHATURVEDI M ， et al . Cancer statistics， 2020： report from national cancer registry programme， India ［J］. JCO Global Oncol ， 2020 ， 6 ： 1063 - 1075 . doi： 10.1200/GO.20.00122 http://dx.doi.org/10.1200/GO.20.00122 .

CHEN W ， ZHENG R ， ZHANG S ， et al . Cancer incidence and mortality in China in 2013： an analysis based on urbanization level ［J］. Chin J Cancer Res ， 2017 ， 29 （ 1 ）： 1 - 10 .

DAZZI C ， CARIELLO A ， CASANOVA C ， et al . Gemcitabine and paclitaxel combination as second-line chemotherapy in patients with small-cell lung cancer： a phase Ⅱ study ［J］. Clin Lung Cancer ， 2013 ， 14 （ 1 ）： 28 - 33 .

CHEN S ， BAO Y ， XU J ， et al . Efficacy and safety of TCM combined with chemotherapy for SCLC： a systematic review and meta-analysis ［J］. J Cancer Res Clin Oncol ， 2020 ， 146 （ 11 ）： 2913 - 2935 .

PARK S ， KIM JY ， LEE JC ， et al . Mobile phone app-based pulmonary rehabilitation for chemotherapy-treated patients with advanced lung cancer： pilot study ［J］. JMIR Mhealth Uhealth ， 2019 ， 7 （ 2 ）： e11094 .

SCHMALZ O ， JACOB C ， AMMANN J ， et al . Digital monitoring and management of patients with advanced or metastatic non-small cell lung cancer treated with cancer immunotherapy and its impact on quality of clinical care： interview and survey study among health care professionals and patients ［J］. J Med Internet Res ， 2020 ， 22 （ 12 ）： e18655 .

辜德英 . 医护一体化“互联网+”随访模式在头颈肿瘤患者随访管理中的应用［J］. 护理实践与研究， 2021 ， 18 （ 11 ）： 1675 - 1679 .

支修益，石远凯，于金明 . 中国原发性肺癌诊疗规范（2015年版）［J］. 中华肿瘤杂志， 2015 ， 37 （ 1 ）： 67 - 78 .

TRAVIS WD ， BRAMBILLA E ， BURKE AP ， et al . Introduction to the 2015 World Health Organization classification of tumors of the lung， pleura， thymus， and heart ［J］. J Thorac Oncol ， 2015 ， 10 （ 9 ）： 1240 - 1242 .

AMIN MB ， GREENE FL ， EDGE SB ， et al . The eighth edition AJCC cancer staging manual： continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging ［J］. CA Cancer J Clin ， 2017 ， 67 （ 2 ）： 93 - 99 .

STAHEL RA ， GINSBERG R ， HAVEMANN K ， et al . Staging and prognostic factors in small cell lung cancer： a consensus report ［J］. Lung Cancer ， 1989 ， 5 （ 4-6 ）： 119 - 126 .

郑筱萸 . 中药新药临床研究指导原则（试行）［M］. 北京：中国医药科技出版社， 2002 ： 216 - 221 ．

林洪生 . 恶性肿瘤中医诊疗指南［M］. 北京：人民卫生出版社， 2014 .

SCHAG CC ， HEINRICH RL ， GANZ PA . Karnofsky performance status revisited： reliability， validity， and guidelines ［J］. J Clin Oncol ， 1984 ， 2 （ 3 ）： 187 - 193 .

KALEMKERIAN GP ， LOO BW ， AKERLEY W ， et al . NCCN guidelines insights： small cell lung cancer， version 2.2018 ［J］. J Natl Compr Canc Netw ， 2018 ， 16 （ 10 ）： 1171 - 1182 .

何姝霖，郭秋均，席玉棚，等 . 花宝金中西医结合治疗化疗敏感的小细胞肺癌临床疗效观察［J］. 北京中医药， 2018 ， 37 （ 12 ）： 1107 - 1110，1115 .

US Food and Drug Administration . Guidance for industry： clinical trial endpoints for the approval of cancer drugs and biologics ［J］. Biotechnol Law Rep ， 2007 ： 375 - 386 . doi： org/10.1089/blr.2007.9941 http://dx.doi.org/org/10.1089/blr.2007.9941 .

张力，洪文松，吴丹进，等 . 基于放疗助手App互动指导的健康教育在肺癌放疗患者康复中的应用［J］. 齐鲁护理杂志， 2019 ， 25 （ 21 ）： 68 - 71 .

DI R ， LI G . Use of a smartphone medical app improves complications and quality of life in patients with nasopharyngeal carcinoma who underwent radiotherapy and chemotherapy ［J］. Med Sci Monit ， 2018 ， 24 ： 6151 - 6156 . doi： 10.12659/MSM.908146 http://dx.doi.org/10.12659/MSM.908146 .

冯慧娜，金建明 . 论中医特色慢病管理的重要性与中医介入优势［J］. 中医药管理杂志， 2021 ， 29 （ 9 ）： 235 - 236 .

ZIMMERMAN S ， DAS A ， WANG S ， et al . 2017-2018 scientific advances in thoracic oncology： small cell lung cancer ［J］. J Thorac Oncol ， 2019 ， 14 （ 5 ）： 768 - 783 .

马满姣，王孟昭，徐燕，等 . 单中心394例广泛期小细胞肺癌的一线化疗及生存分析［J］. 中国肺癌杂志， 2014 ， 17 （ 1 ）： 8 - 14 .

刘倩，任胜祥 . 小细胞肺癌免疫治疗研究进展［J］. 同济大学学报（医学版）， 2021 ， 42 （ 3 ）： 414 - 420 .

徐俏俏，胡鸣旭 . 应用互联网平台对肿瘤患者化疗整体调护作用的研究［J］. 中国卫生信息管理杂志， 2019 ， 16 （ 2 ）： 123 - 126 .

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Differentiation and Treatment of Small Cell Lung Cancer from the Perspective of "Internal Wind in Hidden Circulation"

Treatment of Small Cell Lung Cancer from the Perspective of Wind

Effect of Jianpi Jiedu Formula （健脾解毒方） on Survival Time in Advanced Colorectal Cancer Patients with Synchronous and Metachronous Metastases： A Retrospective Analysis

Chronic Disease Management Model of Myocardial Briding of Mural Coronary Artery with Comprehensive Traditional Chinese Medicine Therapies

Meta-Analysis of Integrative Therapy for Small Cell Lung Cancer

Related Author

FENG Li

SUN Tao

HOU Li

HU Shengjuan

LIU Qing

SUN Jianrong

WANG Ruitao

JIA Liqun

Related Institution

National Cancer Center/ National Clinical Research Center for Cancer/Cancer Hospital，Chinese Academy of Medical Sciences & Peking Union Medical College

Dongfang Hospital，Beijing University of Chinese Medicine

Dongzhimen Hospital，Beijing University of Chinese Medicine

First Clinical Medical College，Beijing University of Chinese Medicine

Japan Friendship Hospital

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰